Vol 14, No 9 (September 30, 2025): Translational Cancer Research

Editorial Commentary

Beyond survival: the role of quality of life in modern urothelial cancer therapy
Shugo Yajima, Hitoshi Masuda
Translational Cancer Research  
2025;
14
(9)
:5178-5180
.

Original Article

B3GNT3 is an oncogenic and prognostic biomarker in human tumors via pan-cancer analysis combined with experimental validation
Ke Shen, Xinhuai Dong, Chong Zeng, Caihong Wu, Guobiao Wu, Jianping Chen, Yansheng Yang, Fengmei Zhong, Yongsheng Huang, Liang Zhao
Translational Cancer Research  
2025;
14
(9)
:5181-5198
.
Combination of Danggui Buxue Tang and concurrent chemoradiotherapy improves treatment outcomes by strengthening B cell immunity in patients with nasopharyngeal carcinoma—a double-blind, randomized trial
He-Yuan Hsieh, Shih-Neng Yang, Ming-Yu Lien, Yao-Ching Wang, Chia-Hao Chang, Han-Kuei Wu, Yu-Cheng Hsu, Ching-Yun Hsieh, Yu-Chuen Huang, Hen-Hong Chang
Translational Cancer Research  
2025;
14
(9)
:5199-5210
.
Development and validation of a gene signature for gastric cancer prognosis based on propionate metabolism
Yizhou Wang, Rui Luo, Ruiyu Wang, Shiqi Li, Yaqi Deng, Ziyan Li, Bojing Wang, Xiaomin Shi, Wei Zhang, Lei Shi, Zhongqiong Wang, Xiaowei Tang
Translational Cancer Research  
2025;
14
(9)
:5211-5225
.
Development and validation of a necroptosis-related gene signature for predicting prognosis and immune infiltration in papillary thyroid cancer
Shiqi Wang, Xiangxiang Zhan, Ying Peng, Dewei Rao, Miao Yang, Yanjun Su, Ruochuan Cheng
Translational Cancer Research  
2025;
14
(9)
:5226-5244
.
A nomogram for predicting overall survival in advanced hepatocellular carcinoma patients receiving radiotherapy combined with targeted therapy: a multicenter retrospective study
Xiaoqin Liu, Bin Zeng, Jun Liu, Yiqing Jiang, Na Wang, Qin Zeng, Ke Xu, Sheng Lin
Translational Cancer Research  
2025;
14
(9)
:5245-5254
.
Efficacy and safety of antibody-drug conjugates in the treatment of non-small cell lung cancer: a systematic review and meta-analysis of prospective clinical trials
Xiaoni Jin, Weixing Zhao, Bo Li, Yujia Gu, Zirui Li, Wanjing Guo, Xinxin Lu, Jun Jiang
Translational Cancer Research  
2025;
14
(9)
:5255-5270
.
KCNJ11 as a prognostic and therapeutic target in colon adenocarcinoma
Jie Chen, Fuyi Xie
Translational Cancer Research  
2025;
14
(9)
:5271-5280
.
Establishment of a prognostic model and immune profiling based on phagocytic regulatory genes in hepatocellular carcinoma
Xiaodong Meng, Qiufang Wang, Yuan Tian, Fei Tian, Siqing Liu, Yiming Wang, Liying Cao, Xiangming Ma
Translational Cancer Research  
2025;
14
(9)
:5281-5296
.
Neochlorogenic acid inhibits gastric cancer cell growth through apoptosis and cell cycle arrest
Wenqiang Sun, Yongchao Li, Menglong Xu, Haocheng Guan, Ruijun Shi, Shuwei Li
Translational Cancer Research  
2025;
14
(9)
:5297-5310
.
Prognostic and predictive roles of circulating microRNAs as biomarkers in head and neck cancer patients in the Northern Territory, Australia undergoing chemoradiotherapy—a pilot prospective cohort study
Shree Ram Lamichhane, Harriet Gee, Natalie Milic, Kar Giam, Thanuja Thachil
Translational Cancer Research  
2025;
14
(9)
:5311-5323
.
Prognostic signature based on hypoxia and RNA methylation regulatory genes can improve the prognostic and recurrence prediction ability of low-grade glioma
Zhina Liu, Huiru Sun, Xiaolong He, Liaoliao Feng, Min Ren, Guangcai Cao
Translational Cancer Research  
2025;
14
(9)
:5324-5341
.
Establishment and characterization of two patient-derived cell lines from a patient with gallbladder carcinoma
Feiling Feng, Minghui Zhu, Yan Feng, Xiaoya Xu, Baoning Nian, Zhikuan Li, Sheng Chen, Xiaofang Li, Zhenghua Xie, Dadong Zhang, Xiangyu Wang, Xiaoqing Jiang
Translational Cancer Research  
2025;
14
(9)
:5342-5352
.
TFAP2A induces cisplatin resistance via BNIP3-mediated mitophagy in non-small cell lung cancer
Li-Li Guo, Xiao-Hua Yang, Hai-Zhen Jin, Ling Tian
Translational Cancer Research  
2025;
14
(9)
:5353-5369
.
The development and validation of a novel programmed cell death-related signature based on machine learning analysis of 15 programmed cell death patterns for predicting prognosis and therapeutic response in high-grade serous ovarian carcinoma
Zhidong Zhang, Wenwen Zhang, Ailin Yao, Pengpeng Qu
Translational Cancer Research  
2025;
14
(9)
:5370-5394
.
Identification of basement membrane-based prognostic signature and potential therapeutic drugs in hepatocellular carcinoma
Guofeng Yu, Yanxi Wu, Wei Xu, Yousheng Yang, Lei Huang, Jianming Ju
Translational Cancer Research  
2025;
14
(9)
:5395-5410
.
The prognostic impact of preoperative radiotherapy in stage I rectal cancer: a retrospective cohort study revealing no survival benefit from SEER database analysis
Shilin Wang, Wen Tang, Xiuquan Li, Qingfeng Jiang, Yanbo Song
Translational Cancer Research  
2025;
14
(9)
:5411-5424
.
FAM83A may serve as a potential prognostic indicator for stomach adenocarcinoma
Dong-Feng Song, Ze-Qing Gu, Ling Qi, Yi-Ming Wu, Li Wang, Meng-Ru Jin, Zhi-Guo Li, Yan-Jing Li
Translational Cancer Research  
2025;
14
(9)
:5425-5440
.
Effect and mechanism of auranofin on extrusion and migration of breast cancer cells
Linyan Ma, Xiaojin Sun, Wei Gao, Pei Zhang, Surong Zhao, Ying Wang, Hao Liu
Translational Cancer Research  
2025;
14
(9)
:5441-5450
.
Integrating prognosis-related genes with immune-related gene signature for development and validation of a survival stratification model for early-stage colorectal cancer
Zhengran Zhou, Xiaobin Zheng, Zerong Cai, Yufeng Chen, Weiqiang You, Zhaoliang Yu, Xi Chen, Yifeng Zou, Xiaojian Wu, Feng Gao, Xuanhui Liu
Translational Cancer Research  
2025;
14
(9)
:5451-5464
.
Nomogram for development and validation of a prognosis prediction model for cancer-specific survival in young breast cancer patients with stage I–III based on the Surveillance, Epidemiology, and End Results (SEER) database
Qianhui Ouyang, Ni Liao, Yan Huang, Jingjing Chen, Chen Zeng, Wei Zhou
Translational Cancer Research  
2025;
14
(9)
:5465-5476
.
A novel machine learning-based predictive model for gastric cancer
Jianxu Yuan, Dalin Zhou, Shengjie Yu
Translational Cancer Research  
2025;
14
(9)
:5477-5489
.
CMTM4 overexpression inhibited tumor growth through regulating the function of myeloid-derived suppressor cells in the cervical cancer microenvironment
Haiyan Wang, Jianhui Liu, Xiaoying A, Jialiang Wang, Qingfen Mu, Anqi Yang, Jing Zhou
Translational Cancer Research  
2025;
14
(9)
:5490-5503
.
Computed tomography-based quantification of intra-tumoral heterogeneity for predicting treatment response to concurrent chemoradiotherapy in non-small cell lung cancer: a multicenter retrospective study
Benlan Li, Zhongjun Huang, Yong Hu, Bo Du, Youlong Mo, Tianchu He, Mingdan Zhao, Ya Li, Min Zhang, Ji Xia, Minfang Wang, Xian Liu, Fangyang Lu, Lingyun Wang, Shengfa Su, Jie Peng
Translational Cancer Research  
2025;
14
(9)
:5504-5519
.
N6-adenosine methyltransferase METTL4 is a potential prognostic biomarker and associates with cell cycle regulation and immune infiltration in glioma
Shuo Zhang, Zhiheng Huang, Shicheng Sun, Shaobin Feng, Kaidi Liu, Longyu Sang, Jingkun Yang, Fan Yang, Rui Zhang, Haitao Fan, Hua Guo
Translational Cancer Research  
2025;
14
(9)
:5520-5533
.
Development of a mitochondrial permeability transition-driven necrosis-linked lncRNA signature for forecasting prognosis and treatment of lung adenocarcinoma
Weibin Luo, Dongfang Li, Da Yao
Translational Cancer Research  
2025;
14
(9)
:5534-5549
.
The relationship and predictive efficacy of serum lipocalin-2, PDK1, NGALR and lymph node metastasis in postmenopausal endometrial cancer
Yuxia Wang, Ge Liu, Ling Qin, Ying Gao
Translational Cancer Research  
2025;
14
(9)
:5550-5558
.
Prognostic factors and overall survival for second primary malignancies in myelodysplastic syndromes: a Cox regression coupled with competing risk model based on Surveillance, Epidemiology, and End Results (SEER) database
Hang Li, Qiang Li, Jinli Ge, Pinwei Zhu, Zhencang Zhou, Nana Zhe
Translational Cancer Research  
2025;
14
(9)
:5559-5571
.
Immunogenomic classification and nomogram development and validation for colorectal cancer survival prediction based on immune-related genes
Guangzhe Shen, Fangze Wei, Tixian Xiao, Fei Huang, Tiezheng Yang, Zhaoxu Zheng
Translational Cancer Research  
2025;
14
(9)
:5572-5585
.
TFP12 as a key regulator of sentinel lymph node metastasis in breast cancer
Aihu An, Bo Song, Bo Gao
Translational Cancer Research  
2025;
14
(9)
:5586-5600
.
Demystifying programmed cell death in lung adenocarcinoma: combined prognostic model construction
Yu Li, Haitao Li, Yuze Zhao, Guantong Liu, Ruijun Lin, Zefeng Xie
Translational Cancer Research  
2025;
14
(9)
:5601-5620
.
Predictive value of random forest prediction model based on postoperative adjuvant transcatheter arterial chemoembolization therapy for survival of hepatocellular carcinoma patients with microvascular invasion: a retrospective cohort study
Yanran Dou, Xin Yang, Jia Song, Yanna Sun
Translational Cancer Research  
2025;
14
(9)
:5621-5636
.
Efficacy and safety of toripalimab in the treatment of patients with non-small cell lung cancer: a systematic review and meta-analysis
Zhiying Wang, Xinwei Liu, Lijun Sheng
Translational Cancer Research  
2025;
14
(9)
:5637-5648
.
MicroRNA-125b inhibits apoptosis and increases gemcitabine resistance by downregulating the expression of BAK1 in pancreatic ductal adenocarcinoma
Jie Sun, Zongxian Zhao, Yuan Yao, Jun Zhang, Rundong Yao, Zongju Hu
Translational Cancer Research  
2025;
14
(9)
:5649-5663
.
Prognostic difference of single metastasis in different sites of hepatocellular carcinoma: a population-based study
Yingjie Zhuang, Qing Chang, Wenhui Liu, Shiping Xu, Xiangye Yin
Translational Cancer Research  
2025;
14
(9)
:5664-5679
.
Integration analysis of single-cell transcriptome reveals SPP1+ and TFF3+ macrophage subsets contributing to the brain metastasis from lung cancer
Zhenli Liu, Xueli Wang, Yuanhui Wang, Guangning Zhang
Translational Cancer Research  
2025;
14
(9)
:5680-5693
.
DTX3 inhibits cell migration, invasion, and epithelial-mesenchymal transition in colorectal cancer through the AKT signaling pathway
Zhennan Ma, Xiuqing Gong, Xiaowei Zhang
Translational Cancer Research  
2025;
14
(9)
:5694-5708
.
Factors affecting chemotherapy-induced peripheral neuropathy in patients with breast cancer: a cross-sectional study in China
Qianqian Zhang, Weimin Liu, Min Wu, Li Xiong, Juan Liu
Translational Cancer Research  
2025;
14
(9)
:5709-5719
.
Constructing a chemokine-based model and identifying CCL17 as a core biomarker associated with immune infiltrates in thyroid cancer
Mimi Zhang, Bing Zou, Qiang Li, Yandong Zhao, Yuejun He
Translational Cancer Research  
2025;
14
(9)
:5720-5744
.
Pan-cancer evaluation of ABAT as an emerging biomarker and its implication in lung adenocarcinoma
Wei Du, Bing-Yu Zhang, Xiao-Wei Wu, Yi-Zhe Gao, Xue Yi
Translational Cancer Research  
2025;
14
(9)
:5745-5763
.
Primary signet-ring cell carcinoma of the bile duct: clinical characteristics, survival comparison with cholangiocarcinoma, and SEER-based prognostic nomograms
Ya Wen, Yi-Biao Zhang, Ai-Hong Yin
Translational Cancer Research  
2025;
14
(9)
:5764-5776
.
APOA2 mediates immune therapy tolerance in hepatocellular carcinoma by inhibiting the antigen-presenting function of dendritic cells through the PPAR signaling pathway
Junwu Guo, Binghua Dai, Hengmei Zhu, Chengjun Sui, Zhitao Dong, Keji Chen, Kecai Duan, Kunpeng Fang, Aijun Li, Feng Xie, Li Geng
Translational Cancer Research  
2025;
14
(9)
:5777-5791
.
Identifying senescent cells as prognostic biomarkers and therapeutic targets of nasopharyngeal carcinoma by integrated analysis of single-cell and bulk-RNA sequencing data
Jiaci Tong, Man He
Translational Cancer Research  
2025;
14
(9)
:5792-5811
.
Adagrasib in the treatment of KRASG12C-mutated non-small cell lung cancer: a cost-effectiveness analysis
Gengwei Huo, Ying Song, Shenge Liu, Xiaoning He, Peng Chen
Translational Cancer Research  
2025;
14
(9)
:5812-5822
.
Circular RNA hsa_circ_0006522 correlates with unfavorable prognosis and promotes the proliferative, migrative, and invasive abilities of breast cancer cells
Xiaoran Wang, Peijin Zhang, Zihao Bai, Lingjiao Meng, Yang Zheng, Meixiang Sang, Cuizhi Geng
Translational Cancer Research  
2025;
14
(9)
:5823-5837
.
Cancer-associated fibroblasts as facilitators in nasopharyngeal carcinoma progression via exosomal MMP13
Haijuan Xiao, Mengdie You, Lixiao Xie, Yingyu Zhang, Zhenxin Zhang, Ziyu Zhu, Qicheng Zhang
Translational Cancer Research  
2025;
14
(9)
:5838-5852
.
Real-time prognosis prediction with conditional survival analysis for skull base chordoma based on SEER
Xiaojia Zhang, Xiaosheng Chen, Jiajie Gu
Translational Cancer Research  
2025;
14
(9)
:5853-5862
.
Pancreatic cancer with liver metastasis benefits from chemoradiotherapy compared to chemotherapy alone: a retrospective cohort study from the Surveillance, Epidemiology, and End Results (SEER) database
Long He, Yunfeng Qiao, Yu Lu, Tao Yin
Translational Cancer Research  
2025;
14
(9)
:5863-5872
.
An immune-related miRNA signature predicts the prognosis in nasopharyngeal carcinoma
Shiyi Wang, Wenting Fu, Shengjie Ge, Xiangyang Wang, Bowen Xue, Guang Li
Translational Cancer Research  
2025;
14
(9)
:5873-5883
.
The role of YTHDF1 in the diagnosis and prognosis of lung adenocarcinoma and its inhibitor LY-411575 in the targeted intervention of lung adenocarcinoma growth
Lei Wang, Chaobo Li, Shuyi Huang, Bin Fan, Cong Wang, Zhihong Yao, Yihao Yang, Lei Han, Daqi Jia, Zuozhang Yang
Translational Cancer Research  
2025;
14
(9)
:5884-5905
.
SNORD93 suppresses colorectal cancer progression by inducing G0/G1 arrest and apoptosis
Yingzhi Xu, Mingzhen Cai, Jiaming Li, Huihui Wu, José María Sayagués, Tingjin Zheng, Zhishan Zhang
Translational Cancer Research  
2025;
14
(9)
:5906-5918
.
Clinical features as prognostic markers in patients with solid tumors treated with programmed cell death protein 1/programmed cell death-ligand 1 inhibitors: a retrospective cohort study
Yanli Liu, Zhe Meng, Lei Hong, Ying Li, Jingli Chen, Qingju Meng, Zhiguo Zhou, Yibing Liu
Translational Cancer Research  
2025;
14
(9)
:5919-5932
.
Development and validation of a lipid metabolism-related prognostic model for gastric adenocarcinoma
Qingyan Li, Pei Zhuang, Danhui Zhang, Di Liu
Translational Cancer Research  
2025;
14
(9)
:5933-5951
.
Pathways linking benefit finding, fear of cancer recurrence, and family support to fertility concerns in women of reproductive age with malignant tumors: a cross-sectional study
Xinying He, Xue Han, Lihua Zeng, Qin Chen, Min Ye, Xuemei Fan, Pengfei Xu, Renata Finelli, Christina M. Moisidis-Tesch, Robert L. Coleman, Chenbo Ji, Chengping Qiao
Translational Cancer Research  
2025;
14
(9)
:5952-5964
.
Association between the age-adjusted visceral adiposity index (AVAI) and gynecologic malignancies: a cross-sectional study based on NHANES data
Xincheng Zhang, Yanran He, Yujie Hui, Pengyu Zhao, Ranran Zhou, Meng Gu, Hooman Soleymani majd, Deyu Zhang
Translational Cancer Research  
2025;
14
(9)
:5965-5978
.
Screening of PANoptosis regulator-associated long noncoding RNAs and construction of a survival prognostic model in cutaneous melanoma
Jingshu Xiong, Mingyang Wu, Jinquan Liu, Li Ma, Yasuhiro Nakamura, Haoze Shi, Jianfang Sun, Hao Chen
Translational Cancer Research  
2025;
14
(9)
:5979-5998
.
METRN modulates immune escape via CD8+ T cells in breast cancer progression through IL-6 signaling pathway
Min Du, Yan Dong, Qian Zhao, Juan Wang, Chunyu Tong, Junxia Zheng, Nadiya Aibaidula, Hao Liu, Yongtao Li, Gang Sun
Translational Cancer Research  
2025;
14
(9)
:5999-6021
.

Review Article

Pathophysiology and perioperative dystrophy of esophagus cancer: association with malnutrition
Qun Cao, Yue Bai, Pingping Kang, Zhuoping Zhang, Xinyu Zhou
Translational Cancer Research  
2025;
14
(9)
:6022-6040
.
The mechanism and research progress of PD-1/PD-L1 on immune escape of lung cancer
Zhenyu Li, Tan Wang, Jimin Liu, Wenlong Qi, Qingguo Lv, Yannan Xu, Lin Tian
Translational Cancer Research  
2025;
14
(9)
:6041-6051
.
PARP-1 in tumor complicated with depression—possible role and therapeutic perspective: a narrative review
Jiajia Qin, Facheng Bai, Dan Ou, Xiaobin Zhong, Jun Deng
Translational Cancer Research  
2025;
14
(9)
:6052-6064
.
Recent advances in development of CDK7 inhibitors and their clinical trials: a narrative review
Lingzhi Zhang, Shiqin Yang, Zhe Guan, Liangyu Lei, Tingting Zhang, Ye Zhang, Xiangyang Miao, Shiqi Wu
Translational Cancer Research  
2025;
14
(9)
:6065-6078
.
A systematic review of multiparametric magnetic resonance imaging radiomics in the prediction of brain invasion in meningioma
Long Yin Huen, Zongyou Cai, Tiffany Y. So, Ye Heng Wong, Qi Yong H. Ai
Translational Cancer Research  
2025;
14
(9)
:6079-6091
.
Multi-gene expression assays in breast cancer: a literature review
Tsung-Yen Hsieh, Chi-Cheng Huang, Ling-Ming Tseng
Translational Cancer Research  
2025;
14
(9)
:6092-6101
.
Prospective proteomics for discovering biomarkers in lung adenocarcinoma: a literature review
Yichen Wang, Mingyue Xu, Xiaoyu Wei, Haitao Huang, Qi Chen, Baofu Chen, Xiaohong Bao, Jicheng Li
Translational Cancer Research  
2025;
14
(9)
:6102-6117
.

Case Report

An innovative surgical approach using the hepatic falciform ligament to repair bronchobiliary fistula after radiofrequency ablation: a case report
Xiang’an Wu, Qidan Hu, Xiaobo Yang, Chi Xu, Jie Pan, Shunda Du, Xinting Sang, Lei Zhang
Translational Cancer Research  
2025;
14
(9)
:6118-6126
.

Letter to the Editor

Response to the letter regarding ‘Construction and validation of a nomogram prediction model for predicting the risk of chemotherapy-induced myelosuppression after chemotherapy in patients with triple-negative breast cancer’
Haoling Xie, Rong Zhang, Chunmei Wei, Jinsong Xu, Xuexing Wang
Translational Cancer Research  
2025;
14
(9)
:6127-6129
.
Incorporating host genetics and inflammation in myelosuppression risk prediction for triple-negative breast cancer
Qingzhu Sun, Shengxia Lv, Yuzhe Zhao, Yongsheng Zhang
Translational Cancer Research  
2025;
14
(9)
:6130-6131
.